Loading
Infection Control in Healthcare / Nosocomial Infections in ICU · Journal article
Infection · August 12, 2026
Encouraging direction, but not yet definitive.
This prospective single-centre evaluation describes the implementation and process outcomes of an automated alert system for last-resort antibiotics followed by infectious diseases specialist review at a large German teaching hospital. ID specialists recommended modifications in approximately 50% of alerts, with projected annual cost savings of €65,092 (€1,549 per initial prescription), but the study does not measure adherence rates, clinical outcomes, or effects on antimicrobial resistance.
Prospective single-centre economic and processual evaluation. Patients at a large tertiary care university hospital (2210 beds) in Germany prescribed last-resort antibiotics.. Intervention: Automated email alert system for last-resort antibiotics (ceftazidime/avibactam, ceftolozane/tazobactam, cefiderocol) followed by mandatory indication review and recommendations by infectious diseases specialists. Single centre in Germany.
ID specialists recommended modifications to antibiotic regime in almost half of alerts, including switching (21%), discontinuation (14%), and dosage modifications (7%) Potential cost savings from de-escalation or discontinuation: €65,092 per year (€1,549 per initial last-resort antibiotic prescription) Respiratory, intraabdominal, and skin/soft tissue infections represented >60% of underlying entities
No measurement of clinical outcomes, mortality, treatment failures, or effects on antimicrobial resistance patterns ID specialists recommended modifications to antibiotic regime in almost half of alerts, including switching (21%), discontinuation (14%), and dosage modifications (7%)
Clinicians implementing antimicrobial stewardship programmes should recognise that automated alerts combined with specialist review can identify prescribing changes in roughly half of last-resort antibiotic orders with substantial projected cost savings. However, confirmation of adherence, clinical safety, and generalisability to non-tertiary settings is needed before widespread adoption.
A sound single-centre prospective evaluation showing meaningful process improvements (modifications in ~50% of alerts) and substantial projected cost savings, but lacking hard clinical outcomes, resistance data, or patient-level impact measurement.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians implementing antimicrobial stewardship programmes should recognise that automated alerts combined with specialist review can identify prescribing changes in roughly half of last-resort antibiotic orders with substantial projected cost savings. However, confirmation of adherence, clinical safety, and generalisability to non-tertiary settings is needed before widespread adoption.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Abstract Purpose Infections caused by resistant pathogens represent a global public health challenge. In the current study we aimed to assess the effects on prescription quality and the economic impact of implementing an automated email alert system for last-resort antibiotics, followed by mandatory indication review by infectious diseases (ID) specialists. Methods A prospective single-centre economic and processual evaluation study of orders of last-resort antibiotics at a large tertiary care university hospital (2210 beds) in Germany was performed. Orders of ceftazidime/avibactam, ceftolozane/tazobactam, or cefiderocol triggered an indication review by ID specialists with subsequent recommendations to the primary treating physicians. Expected medication costs of continued therapy were compared to projected costs with adherence to ID recommendations. Results The spectrum of infections for which last-resort antibiotics were prescribed was broad, with respiratory, intraabdominal, skin and soft tissue infections representing > 60% of underlying entities. Dominant pathogens were Pseudomonas aeruginosa, Klebsiella spp. and Escherichia coli. ID specialists recommended modifications to the antibiotic regime in almost half of the alerts, including switching (21%), discontinuation (14%) and dosage modifications (7%). Potential cost savings by de-escalation to non-last-resort antibiotics or treatment discontinuation were 65,092€ per year (1,549 € per initial last-resort antibiotic prescription). Adherence analysis revealed that further improvement appears feasible, potentially through structured follow-up ID consultations. Conclusion Implementation of automated last-resort antibiotic alerts, followed by an indication review by ID specialists, proved to be a valuable tool with respect to prescription quality and economic benefits. Generalisability of this approach should be investigated in non-tertiary care settings. Moreover, future studies should address potential effects on clinical outcomes and antimicrobial resistance patterns.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.